Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × obinutuzumab × Clear all

Phase

Status

Completed 81 Recruiting 73 Active not recruiting 44 Terminated 31 Not yet recruiting 13 Unknown 8 Withdrawn 5 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Lymphoma, B-Cell 1

Interventions

Specimen Handling 34 Magnetic Resonance Spectroscopy 22 Cyclophosphamide 18 Biopsy 18 Vincristine 10 Paclitaxel 10 Nivolumab 10 Doxorubicin 9 Cisplatin 9 pembrolizumab 8 Prednisone 8 Bevacizumab 8 Rituximab 7 Radiotherapy 7 Etoposide 7 Azacitidine 7 venetoclax 6 Radiation 6 Gemcitabine 6 Fluorouracil 6 Drug Therapy 6 Docetaxel 6 Carboplatin 6 Radiosurgery 5 Oxaliplatin 5 Irinotecan 5 Injections 5 Capecitabine 5 prednylidene 4 fludarabine phosphate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06824701 2026-04-06

TARZAN

University of Utah

Phase 1 Suspended

Recurrence, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡